Switzerland Eye Research Institute Publishes Breakthrough Case Report Using Light Exposure and Nutraceuticals for Treating Retinal Degeneration

Roberto Pinelli, MD, CEO of the Switzerland Eye Research Institute, announced the publication of a breakthrough paper in Archives Italiennes de Biologie. The report can be found here: http://www.architalbiol.org/index.php/aib/article/view/159134

“The neurobiology of nutraceuticals combined with light exposure has solved a case of age related macular degeneration, AMD; the drusen disappeared in 6 months after this treatment called Lugano Protocol,” Dr Pinelli said.

The Department of Chemistry and Biochemistry, and the College of Health and Human Services, San Diego State University, are represented by Dr. Violet Vakunseh Bumah. The Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa and IRCCS Neuromed Pozzili, Italy, were represented by Prof. Francesco Fornai.'

“The scientific innovation involves the neuroregeneration of cells, by the combination of specific phytochemicals and photobiomodulation," Dr. Pinelli said. "The mitochondria reacts by activating ATP production in the photoreceptors in AMD and this combination of energies (light radiation and phytochemical property) helps in autophagia and in the process, maintains the integrity of the retinal tissue."

This paper is opening a new door into the role of light and nutraceuticals in neuroscience of the eye through the retina—a “stargate” to the nervous system—and potentially in the direction of the neurodegenerative pathologies.